Detalhe da pesquisa
1.
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study.
Lancet Oncol
; 19(5): 682-693, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29625879
2.
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.
Br J Cancer
; 119(1): 19-26, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29808014
3.
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial.
Pharmacol Res
; 132: 72-79, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29614381
4.
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.
Lancet Oncol
; 16(7): 859-70, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26095784
5.
Impressive response to denosumab in a patient with bone metastatic adenocarcinoma of the stomach after 2 years of zoledronic acid.
Anticancer Drugs
; 26(2): 232-5, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25243456
6.
Real-world study of everolimus in advanced progressive neuroendocrine tumors.
Oncologist
; 19(9): 966-74, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-25117065
7.
Extra-gastrointestinal stromal tumor of the pancreas: case report and review of the literature.
World J Surg Oncol
; 12: 105, 2014 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-24755359
8.
ABO-Incompatible Orthotopic Liver Transplant as a Rescue Strategy for Fulminant Hepatic Failure in a Recipient With Breast Cancer: Highlights on Transplant Management.
Exp Clin Transplant
; 21(9): 779-783, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37885295
9.
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study.
Target Oncol
; 17(4): 467-474, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35751733
10.
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety.
Hepatology
; 51(1): 165-73, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-19877181
11.
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study.
Eur J Cancer
; 147: 120-127, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33647547
12.
Real-world study of everolimus in advanced progressive neuroendocrine tumors.
Oncologist
; 20(5): 570, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25956900
13.
Good response to second-line bevacizumab and interferon-alpha in a sunitinib-refractory patient with metastatic renal cell carcinoma.
Anticancer Drugs
; 21(2): 210-3, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19952729
14.
Capecitabine in advanced hepatocellular carcinoma: A multicenter experience.
Dig Liver Dis
; 51(12): 1713-1719, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31320302
15.
Aggressive behaviour of solid-pseudopapillary tumor of the pancreas in adults: a case report and review of the literature.
World J Gastroenterol
; 14(6): 960-5, 2008 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-18240360
16.
A phase II study of gemcitabine at fixed infusion rate of 10 mg/m2/min with or without immunotherapy in advanced renal cancer.
Anticancer Res
; 27(6C): 4461-4, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-18214061
17.
A phase I study of cisplatin, temozolomide and thalidomide in patients with malignant brain tumors.
Anticancer Res
; 27(2): 1019-24, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-17465237
18.
Circulating endothelial cells and risk of progression in patients with hepatocellular cancer receiving sorafenib.
Hepat Oncol
; 4(2): 39-43, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-30191052
19.
Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma.
World J Gastroenterol
; 23(13): 2448-2452, 2017 Apr 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28428725
20.
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study.
Eur J Cancer
; 81: 17-25, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28591675